4-Chloro-7-methoxyquinoline-6-carboxamide (CAS No: 417721-36-9) is a key pharmaceutical intermediate used in the synthesis of APIs Lenvatinib. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Lenvatinib Impurity 20, 7-methoxy-4-chloro-quinoline-6-carboxamide
CAS No: 417721-36-9
PubChem CID: 22936418
Mol Formula: C11H9ClN2O2
Mol Weight: 236.65 g/mol
Used in API: Lenvatinib
IUPAC Name: 4-chloro-7-methoxyquinoline-6-carboxamide
API Intermediate Description: 4-Chloro-7-methoxyquinoline-6-carboxamide is a crucial pharmaceutical intermediate primarily used in synthesizing the anti-cancer drug Lenvatinib, a multi-receptor tyrosine kinase inhibitor for treating thyroid, liver, and kidney cancers. As a building block, its quinoline structure allows for the creation of complex molecules targeting specific enzymes in diseases, making it vital in medicinal chemistry for developing new antimalarial, antibacterial, and anticancer agents.
